Back 'Estimated sustainable cost-based prices for diabetes medicines', JAMA Network Open , 7/3, ee243474
Additionally, people with multiple weight-related health conditionssuch as type 2 diabetes and hypertensionoften benefit from controlled, gradual activation of GLP-1 signaling to avoid acute changes in blood glucose or blood pressure
Unlike tirzepatide, it is a triple agonist , acting on GLP-1, GIP, and glucagon receptors
References: Sikiric P et al., Curr Pharm Des, 2018 24(18):20022030 Goldstein AL et al., Ann NY Acad Sci, 2007 1112:148154 Getting SJ et al., J Immunol, 1999 163(10):59595967 Pickart L et al., Biochim Biophys Acta, 2015 1850(8):18631885 $155.00 Los productos llegarn en forma liofilizada (polvo) para mxima estabilidad